ENHANCE trial: unlocking the immune secrets of breast cancer treatment
NCT ID NCT04897009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how chemotherapy given before surgery affects the immune system in people with operable breast cancer. Researchers will collect blood samples to see if certain immune cells can predict how well the tumor responds to treatment. The goal is to better understand the link between the immune system and breast cancer therapy, which could lead to more personalized care in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Could a common cholesterol drug boost breast cancer treatment?
- Gene test could guide breast cancer treatment to boost survival
- One-Week radiation for breast cancer: MRI precision may cut side effects
- Could a single day of radiation replace weeks of treatment for breast cancer?
- Radiation may offer better quality of life than hormone pills for older breast cancer patients